Lower levels of histidine have been attributed to higher histidine decarboxylase activity, resulting in the accelerated decarboxylation of histidine to histamine, a mediator involved in inflammatory and immune responses associated with cancer initiation and progression [43]. The gene discussed is HDC; the disease is cancer.